Ciarán Doneganمشاهده پروفایل
پژوهشگر ارشد
Ciarán Donegan is a Research Fellow in the Machine Learning group at the Technical University of Berlin and BIFOLD (Berlin Institute for the Foundations of Learning and Data), with a concurrent guest researcher position in the Ohler Lab at the Max Delbrück Center for Molecular Medicine. His primary research focuses on applying deep learning methodologies to elucidate gene regulation mechanisms within molecular biology. Education: M.A.I. in Electronic & Computer Engineering from Trinity College Dublin (2021) B.A.I. in Electronic & Computer Engineering from Trinity College Dublin (2020) His research program integrates Regulatory Genomics with cutting-edge machine learning techniques, emphasizing Explainable AI frameworks and Geometric Deep Learning architectures. This interdisciplinary approach targets complex biological systems, particularly in modeling transcriptional regulation and epigenetic modifications through neural network interpretability. Applications extend to disease mechanism analysis and therapeutic target identification in life sciences contexts. Publication trends reveal dual-domain expertise: the 2022 sports broadcasting paper demonstrates real-time computer vision capabilities for automated production systems, while the 2021 VPU-specific CNN research pioneers hardware-aware neural architecture search. These works collectively underscore a methodological thread in optimizing deep learning for constrained environments—whether computational (edge devices) or operational (live sports)—while maintaining biological research as his core focus area. No scientific awards were documented in the source materials. Advisory activities and grant funding details remain unspecified in available records. He operates within collaborative research ecosystems spanning TU Berlin's Machine Learning group, BIFOLD's interdisciplinary data science initiatives, and the Ohler Lab's genomic regulatory studies at the Max Delbrück Center, facilitating cross-institutional innovation in AI-driven life sciences.



